Top

Published in:

Open Access 01-06-2018

Consumer credit as a novel marker for economic burden and health after cancer in a diverse population of breast cancer survivors in the USA

Authors: Lorraine T. Dean, Kathryn H. Schmitz, Kevin D. Frick, Lauren H. Nicholas, Yuehan Zhang, S. V. Subramanian, Kala Visvanathan

Published in: Journal of Cancer Survivorship | Issue 3/2018

Abstract

Background

Consumer credit may reflect financial hardship that patients face due to cancer treatment, which in turn may impact ability to manage health after cancer; however, credit’s relationship to economic burden and health after cancer has not been evaluated.

Methods

From May to September 2015, 123 women with a history of breast cancer residing in Pennsylvania or New Jersey completed a cross-sectional survey of demographics, socioeconomic position, comorbidities, SF-12 self-rated health, economic burden since cancer diagnosis, psychosocial stress, and self-reported (poor to excellent) credit quality. Ordinal logistic regression evaluated credit’s contribution to economic burden and self-rated health.

Results

Mean respondent age was 64 years. Mean year from diagnosis was 11.5. Forty percent of respondents were Black or Other and 60% were White. Twenty-four percent self-reported poor credit, and 76% reported good to excellent credit quality. In adjusted models, changing income, using savings, borrowing money, and being unable to purchase a health need since cancer were associated with poorer credit. Better credit was associated with 7.72 ([1.22, 14.20], p = 0.02) higher physical health t-score, and a − 2.00 ([− 3.92, − 0.09], p = 0.04) point change in psychosocial stress.

Conclusions

This exploratory analysis establishes the premise for consumer credit as a marker of economic burden and health for breast cancer survivors. Future work should validate these findings in larger samples and for other health conditions.

Implications for Cancer Survivors

Stabilizing and monitoring consumer credit may be a potential intervention point for mitigating economic burden after breast cancer.

Jagsi R, Pottow JA, Griffith KA, Bradley C, Hamilton AS, Graff J, et al. Long-term financial burden of breast cancer: experiences of a diverse cohort of survivors identified through population-based registries. J Clin Oncol. 2014;32(12):1269–76. https://doi.org/10.1200/JCO.2013.53.0956.CrossRefPubMedPubMedCentral

Bernard DS, Farr SL, Fang Z. National estimates of out-of-pocket health care expenditure burdens among nonelderly adults with cancer: 2001 to 2008. J Clin Oncol. 2011;29(20):2821–6. https://doi.org/10.1200/JCO.2010.33.0522.CrossRefPubMedPubMedCentral

Guy GP, Yabroff KR, Ekwueme DU, Virgo KS, Han X, Banegas MP, et al. Healthcare expenditure burden among non-elderly cancer survivors, 2008–2012. Am J Prev Med. 2015;49(6):S489–S97. https://doi.org/10.1016/j.amepre.2015.09.002.CrossRefPubMedPubMedCentral

Zafar SY. Financial toxicity of cancer care: it’s time to intervene. J Natl Cancer Inst. 2016;108(5):djv370. https://doi.org/10.1093/jnci/djv370.CrossRefPubMed

Zafar SY, Abernethy AP. Financial toxicity, part I: a new name for a growing problem. Oncology (Williston Park). 2013;27(2):80–1. 149

Zafar SY, Peppercorn JM, Schrag D, Taylor DH, Goetzinger AM, Zhong X, et al. The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience. Oncologist. 2013;18(4):381–90. https://doi.org/10.1634/theoncologist.2012-0279.

Arozullah AM, Calhoun EA, Wolf M, Finley D, Fitzner KA, Heckinger EA, et al. The financial burden of cancer: estimates from a study of insured women with breast cancer. J Support Oncol. 2004;2(3):271–8.PubMed

Pisu M, Azuero A, McNees P, Burkhardt J, Benz R, Meneses K. The out of pocket cost of breast cancer survivors: a review. J Cancer Surviv. 2010;4(3):202–9. https://doi.org/10.1007/s11764-010-0125-y.CrossRefPubMedPubMedCentral

Finkelstein EA, Tangka FK, Trogdon JG, Sabatino SA, Richardson LC. The personal financial burden of cancer for the working-aged population. 2009.

10.

Latremouille-Viau D, Chang J, Guerin A, Shi S, Wang E, Yu J, et al. The economic burden of common adverse events associated with metastatic colorectal cancer treatment in the United States. J Med Econ. 2017;20(1):54–62. https://doi.org/10.1080/13696998.2016.1225577.

11.

Narang AK, Nicholas LH. Out-of-pocket spending and financial burden among medicare beneficiaries with cancer. JAMA Oncology. 2016;

12.

Barron JJ, Quimbo R, Nikam PT, Amonkar MM. Assessing the economic burden of breast cancer in a US managed care population. Breast Cancer Res Treat. 2008;109(2):367–77. https://doi.org/10.1007/s10549-007-9650-4.CrossRefPubMed

13.

Pisu M, Azuero A, Benz R, McNees P, Meneses K. Out-of-pocket costs and burden among rural breast cancer survivors. Cancer Med. 2017;6(3):572–81. https://doi.org/10.1002/cam4.1017.CrossRefPubMedPubMedCentral

14.

Altice CK, Banegas MP, Tucker-Seeley RD, Yabroff KR. Financial hardships experienced by cancer survivors: a systematic review. J Natl Cancer Inst. 2017;109(2):djw205. https://doi.org/10.1093/jnci/djw205.CrossRefPubMed

15.

Banegas MP, Guy GP, de Moor JS, Ekwueme DU, Virgo KS, Kent EE, et al. For working-age cancer survivors, medical debt and bankruptcy create financial hardships. Health Aff. 2016;35(1):54–61. https://doi.org/10.1377/hlthaff.2015.0830.

16.

Ramsey S, Blough D, Kirchhoff A, Kreizenbeck K, Fedorenko C, Snell K, et al. Washington State cancer patients found to be at greater risk for bankruptcy than people without a cancer diagnosis. Health Aff. 2013;32(6):1143–52. https://doi.org/10.1377/hlthaff.2012.1263.

17.

Ramsey SD, Bansal A, Fedorenko CR, Blough DK, Overstreet KA, Shankaran V, et al. Financial insolvency as a risk factor for early mortality among patients with cancer. J Clin Oncol. 2016;34(9):980–6. https://doi.org/10.1200/JCO.2015.64.6620.

18.

Shih Y-CT XY, Cormier JN, Giordano S, Ridner SH, Buchholz TA, et al. Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study. J Clin Oncol. 2009;27(12):2007–14. https://doi.org/10.1200/JCO.2008.18.3517.CrossRef

19.

Bennett CL, Calhoun EA. Evaluating the total costs of chemotherapy-induced febrile neutropenia: results from a pilot study with community oncology cancer patients. Oncologist. 2007;12(4):478–83. https://doi.org/10.1634/theoncologist.12-4-478.CrossRefPubMed

20.

Schmitz KH, DiSipio T, Gordon LG, Hayes SC. Adverse breast cancer treatment effects: the economic case for making rehabilitative programs standard of care. Support Care Cancer. 2015;23(6):1807–17. https://doi.org/10.1007/s00520-014-2539-y.CrossRefPubMed

21.

Schnur JB, Zivin JG, Mattson DM Jr, Green S, Jandorf LH, Wernicke AG, et al. Acute skin toxicity-related, out-of-pocket expenses in patients with breast cancer treated with external beam radiotherapy. Support Care Cancer. 2012;20(12):3105–13. https://doi.org/10.1007/s00520-012-1435-6.CrossRefPubMedPubMedCentral

22.

Bilir SP et al. Economic burden of toxicities associated with treating metastatic melanoma in the United States. Am Health Drug Benefits. 2016;9(4):203–13.

23.

Irwin DE, Masaquel A, Johnston S, Barnett B. Adverse event-related costs for systemic metastatic breast cancer treatment among female Medicaid beneficiaries. J Med Econ. 2016;19(11):1027–33. https://doi.org/10.1080/13696998.2016.1192548.CrossRefPubMed

24.

Hansen RN, Ramsey SD, Lalla D, Masaquel A, Kamath T, Brammer M, et al. Identification and cost of adverse events in metastatic breast cancer in taxane and capecitabine based regimens. Spring. 2014;3(1):259. https://doi.org/10.1186/2193-1801-3-259.

25.

Hurvitz S, Guerin A, Brammer M, Guardino E, Zhou Z-Y, Viau DL, et al. Investigation of adverse-event-related costs for patients with metastatic breast cancer in a real-world setting. Oncologist. 2014;19(9):901–8. https://doi.org/10.1634/theoncologist.2014-0059.CrossRefPubMedPubMedCentral

26.

Rashid N, Koh HA, Baca HC, Lin KJ, Malecha SE, Masaquel A. Economic burden related to chemotherapy-related adverse events in patients with metastatic breast cancer in an integrated health care system. Breast Cancer Targets Ther. 2016;8:173. https://doi.org/10.2147/BCTT.S105618.

27.

Davidoff AJ, Erten M, Shaffer T, Shoemaker JS, Zuckerman IH, Pandya N, et al. Out-of-pocket health care expenditure burden for Medicare beneficiaries with cancer. Cancer. 2013;119(6):1257–65. https://doi.org/10.1002/cncr.27848.

28.

Tucker-Seeley RD, Yabroff KR. Minimizing the “financial toxicity” associated with cancer care: advancing the research agenda. J Natl Cancer Inst. 2016;108(5):djv410. https://doi.org/10.1093/jnci/djv410.CrossRefPubMed

29.

Cheng K, Wong W, Koh C. Unmet needs mediate the relationship between symptoms and quality of life in breast cancer survivors. Support Care Cancer. 2016;24(5):2025–33. https://doi.org/10.1007/s00520-015-2994-0.CrossRefPubMed

30.

Meeker CR, Geynisman DM, Egleston BL, Hall MJ, Mechanic KY, Bilusic M, et al. Relationships among financial distress, emotional distress, and overall distress in insured patients with cancer. J Oncol Pract. 2016:JOPR011049;12(7):e755–64. https://doi.org/10.1200/JOP.2016.011049.

31.

de Souza JA, Yap BJ, Wroblewski K, Blinder V, Araujo FS, Hlubocky FJ, et al. Measuring financial toxicity as a clinically relevant patient-reported outcome: the validation of the COmprehensive Score for financial Toxicity. Cancer. 2016;123(3):476–84. https://doi.org/10.1002/cncr.30369.CrossRefPubMedPubMedCentral

32.

de Jong M, Tamminga SJ, Frings-Dresen MHW, de Boer AGEM. Quality of Working Life of cancer survivors: associations with health- and work-related variables. Support Care Cancer. 2017;25(5):1475–84. https://doi.org/10.1007/s00520-016-3549-8.CrossRefPubMed

33.

Kale HP, Carroll NV. Self-reported financial burden of cancer care and its effect on physical and mental health-related quality of life among US cancer survivors. Cancer. 2016;122(8):283–9. https://doi.org/10.1002/cncr.29808.CrossRefPubMed

34.

Souza JA, Yap BJ, Hlubocky FJ, Wroblewski K, Ratain MJ, Cella D, et al. The development of a financial toxicity patient-reported outcome in cancer: the COST measure. Cancer. 2014;120(20):3245–53. https://doi.org/10.1002/cncr.28814.CrossRefPubMed

35.

Pisu M, Azuero A, Meneses K, Burkhardt J, McNees P. Out of pocket cost comparison between Caucasian and minority breast cancer survivors in the Breast Cancer Education Intervention (BCEI). Breast Cancer Res Treat. 2011;127(2):521–9. https://doi.org/10.1007/s10549-010-1225-0.CrossRefPubMed

36.

Timmons A, Gooberman-Hill R, Sharp L. “It’s at a time in your life when you are most vulnerable”: a qualitative exploration of the financial impact of a cancer diagnosis and implications for financial protection in health. PLoS One. 2013;8(11):e77549. https://doi.org/10.1371/journal.pone.0077549.CrossRefPubMedPubMedCentral

37.

Oatis W, Nonzee N, Markossian T, Shankaran V, McKoy J, Evens A, et al. Interpreting out-of-pocket expenditures for cancer patients: the importance of considering baseline household income information. J Clin Oncol. 2009;27(15S):6541. https://doi.org/10.1200/jco.2009.27.15s.6541

38.

Richardson T, Elliott P, Roberts R. The relationship between personal unsecured debt and mental and physical health: a systematic review and meta-analysis. Clin Psychol Rev. 2013;33(8):1148–62. https://doi.org/10.1016/j.cpr.2013.08.009.CrossRefPubMed

39.

Turunen E, Hiilamo H. Health effects of indebtedness: a systematic review. BMC Public Health. 2014;14(1):489. https://doi.org/10.1186/1471-2458-14-489.CrossRefPubMedPubMedCentral

40.

Israel S, Caspi A, Belsky DW, Harrington H, Hogan S, Houts R, et al. Credit scores, cardiovascular disease risk, and human capital. Proc Natl Acad Sci U S A. 2014;111(48):17087–92. https://doi.org/10.1073/pnas.1409794111.CrossRefPubMedPubMedCentral

41.

Li Y, Gao J, Enkavi AZ, Zaval L, Weber EU, Johnson EJ. Sound credit scores and financial decisions despite cognitive aging. Proc Natl Acad Sci. 2015;112(1):65–9. https://doi.org/10.1073/pnas.1413570112.CrossRefPubMed

42.

Brockett PL, Golden LL. Biological and psychobehavioral correlates of credit scores and automobile insurance losses: toward an explication of why credit scoring works. J Risk Insur. 2007;74(1):23–63. https://doi.org/10.1111/j.1539-6975.2007.00201.x.CrossRef

43.

Houle JN, Collins JM, Schmeiser MD. Flu and finances: influenza outbreaks and loan defaults in US cities, 2004–2012. Am J Public Health. 2015;105(9):e75–80. https://doi.org/10.2105/AJPH.2015.302671.CrossRefPubMedPubMedCentral

44.

Lee Y, Song I. A study on the economic factor associated with suicide: debt and suicide ideation. Mental Health Soc Work. 2015;43(1):58–82.

45.

Stegman MA, Quercia RG, Ratcliffe J, Ding L, Davis WR. Preventive servicing is good for business and affordable homeownership policy. Housing Policy Debate. 2007;18(2):243–78. https://doi.org/10.1080/10511482.2007.9521600.CrossRef

46.

Schmitz KH, Ahmed RL, Troxel AB, Cheville A, Lewis-Grant L, Smith R, et al. Weight lifting for women at risk for breast cancer–related lymphedema: a randomized trial. JAMA. 2010;304(24):2699–705. https://doi.org/10.1001/jama.2010.1837.

47.

Schmitz KH, Troxel AB, Cheville A, Grant LL, Bryan CJ, Gross CR, et al. Physical Activity and Lymphedema (the PAL trial): assessing the safety of progressive strength training in breast cancer survivors. Contemp Clin Trials. 2009;30(3):233–45. https://doi.org/10.1016/j.cct.2009.01.001.

48.

Patterson RE, Colditz GA, Hu FB, Schmitz KH, Ahima RS, Brownson RC, et al. The 2011–2016 Transdisciplinary Research on Energetics and Cancer (TREC) initiative: rationale and design. Cancer Causes Control. 2013;24(4):695–704. https://doi.org/10.1007/s10552-013-0150-z.

49.

Adler N, Singh-Manoux A, Schwartz J, Stewart J, Matthews K, Marmot MG. Social status and health: a comparison of British civil servants in Whitehall-II with European-and African-Americans in CARDIA. Soc Sci Med. 2008;66(5):1034–45. https://doi.org/10.1016/j.socscimed.2007.11.031.CrossRefPubMed

50.

Berkman L, Macintyre S. The measurement of social class in health studies: old measures and new formulations. IARC Sci Publ. 1997;138(51)

51.

Oberst K, Bradley CJ, Schenk M. Breast and prostate cancer patient’s reliability of treatment reporting. J Registry Manag. 2008;36(1):12–5.

52.

Gordon L, Scuffham P, Hayes S, Newman B. Exploring the economic impact of breast cancers during the 18 months following diagnosis. Psycho Onocol. 2007;16(12):1130–9. https://doi.org/10.1002/pon.1182.CrossRef

53.

Given BA, Given CW, Stommel M. Family and out of pocket costs for women with breast cancer. Cancer Pract. 1994;2(3):187–93.PubMed

54.

Ware JE Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220–33. https://doi.org/10.1097/00005650-199603000-00003.CrossRefPubMed

55.

Cohen S, Williamson G. Perceived stress in a probability sample of the US. In: Spacapam S, Oskamp S, editors. The social psychology of health: Claremont symposium on applied social psychology. Newbury Park, CA: Sage; 1988.

56.

Ware JE KM, Keller SD. SF-12: how to score the SF-12 Physical and Mental Health Summary Scales, Second Edition. Boston, MA 1995.

57.

Cohen S, JANICKI-DEVERTS D. Who’s stressed? Distributions of psychological stress in the United States in probability samples from 1983, 2006, and 20091. J Appl Soc Psychol. 2012;42(6):1320–34. https://doi.org/10.1111/j.1559-1816.2012.00900.x.CrossRef

58.

Darby K, Davis C, Likes W, Bell J. Exploring the financial impact of breast cancer for African American medically underserved women: a qualitative study. J Health Care Poor Underserved. 2009;20(3):721–8. https://doi.org/10.1353/hpu.0.0176.CrossRefPubMed

59.

De Boer AG, Taskila T, Ojajärvi A, van Dijk FJ, Verbeek JH. Cancer survivors and unemployment: a meta-analysis and meta-regression. JAMA. 2009;301(7):753–62. https://doi.org/10.1001/jama.2009.187.CrossRefPubMed

60.

Yin W, Horblyuk R, Perkins JJ, Sison S, Smith G, Snider JT, et al. Association between breast cancer disease progression and workplace productivity in the United States. J Occup Environ Med. 2017;59(2):198–204. https://doi.org/10.1097/JOM.0000000000000936.

61.

Hasegawa T, Goto N, Matsumoto N, Sasaki Y, Ishiguro T, Kuzuya N, et al. Prevalence of unmet needs and correlated factors in advanced-stage cancer patients receiving rehabilitation. Support Care Cancer. 2016;24(11):4761–7. https://doi.org/10.1007/s00520-016-3327-7.

62.

Bower JEG, Patricia A. Symptoms: fatigue and cognitive function. In: Ganz PA, editor. Improving outcomes for breast cancer survivors. Springer; 2015. p. 53–76.

63.

Solís CB, Fantin R, Castagné R, Lang T, Delpierre C, Kelly-Irving M. Mediating pathways between parental socio-economic position and allostatic load in mid-life: findings from the 1958 British birth cohort. Soc Sci Med. 2016;165:19–27. https://doi.org/10.1016/j.socscimed.2016.07.031.CrossRef

64.

Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System 2016 Summary Data Quality Report2017 29 June 2017.

65.

Khera N, Holland JC, Griffin JM. Setting the stage for universal financial distress screening in routine cancer care. Cancer. 2017;123(21):4092–6. https://doi.org/10.1002/cncr.30940.

Title: Consumer credit as a novel marker for economic burden and health after cancer in a diverse population of breast cancer survivors in the USA
Authors: Lorraine T. Dean
Kathryn H. Schmitz
Kevin D. Frick
Lauren H. Nicholas
Yuehan Zhang
S. V. Subramanian
Kala Visvanathan
Publication date: 01-06-2018
Publisher: Springer US
Published in: Journal of Cancer Survivorship / Issue 3/2018
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI: https://doi.org/10.1007/s11764-017-0669-1

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Implications for Cancer Survivors

Please log in to get access to this content

Other articles of this Issue 3/2018

Evolution of neurocognitive function in long-term survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only

Development of the Cancer Survivor Profile-Breast Cancer (CSPro-BC) app: patient and nurse perspectives on a new navigation tool

Survivorship care plan outcomes for primary care physicians, cancer survivors, and systems: a scoping review

Feasibility and preliminary efficacy of an exercise telephone counseling intervention for hematologic cancer survivors: a phase II randomized controlled trial

Cardiovascular disease incidence in adolescent and young adult cancer survivors: a retrospective cohort study

Fatigue and depressive symptoms improve but remain negatively related to work functioning over 18 months after return to work in cancer patients

Keynote webinar | Spotlight on antibody–drug conjugates in cancer